{ "generatedAt": "2026-06-19T00:40:21.011Z", "source": "DrugsMonitor glossary", "recordCount": 35, "records": [ { "slug": "mdl", "term": "Multidistrict Litigation (MDL)", "definition": "A legal procedure that consolidates similar civil cases from different federal districts before a single judge for pretrial proceedings.", "category": "Legal Procedure", "url": "https://drugsmonitor.com/glossary/mdl", "markdownUrl": "https://drugsmonitor.com/data/glossary/mdl.md" }, { "slug": "mass-tort", "term": "Mass Tort", "definition": "A civil action where many plaintiffs sue one or a few defendants for similar harms caused by the same product, drug, or exposure.", "category": "Legal Procedure", "url": "https://drugsmonitor.com/glossary/mass-tort", "markdownUrl": "https://drugsmonitor.com/data/glossary/mass-tort.md" }, { "slug": "bellwether-trial", "term": "Bellwether Trial", "definition": "A sample trial selected from a group of mass tort cases to test how juries respond to representative evidence and claims.", "category": "Legal Procedure", "url": "https://drugsmonitor.com/glossary/bellwether-trial", "markdownUrl": "https://drugsmonitor.com/data/glossary/bellwether-trial.md" }, { "slug": "statute-of-limitations", "term": "Statute of Limitations", "definition": "A law setting the maximum time period after an event within which legal proceedings may be initiated.", "category": "Legal Procedure", "url": "https://drugsmonitor.com/glossary/statute-of-limitations", "markdownUrl": "https://drugsmonitor.com/data/glossary/statute-of-limitations.md" }, { "slug": "statute-of-repose", "term": "Statute of Repose", "definition": "An absolute deadline barring any lawsuit after a specified number of years from a product's sale or first use, regardless of when the injury was discovered.", "category": "Legal Procedure", "url": "https://drugsmonitor.com/glossary/statute-of-repose", "markdownUrl": "https://drugsmonitor.com/data/glossary/statute-of-repose.md" }, { "slug": "product-liability", "term": "Product Liability", "definition": "The legal responsibility of manufacturers and sellers for injuries caused by defective products they place into the marketplace.", "category": "Legal Theory", "url": "https://drugsmonitor.com/glossary/product-liability", "markdownUrl": "https://drugsmonitor.com/data/glossary/product-liability.md" }, { "slug": "failure-to-warn", "term": "Failure to Warn", "definition": "A product liability claim alleging that a manufacturer did not adequately communicate known or knowable risks associated with its product.", "category": "Legal Theory", "url": "https://drugsmonitor.com/glossary/failure-to-warn", "markdownUrl": "https://drugsmonitor.com/data/glossary/failure-to-warn.md" }, { "slug": "learned-intermediary", "term": "Learned Intermediary Doctrine", "definition": "A legal principle holding that drug manufacturers fulfill their duty to warn by providing adequate information to prescribing physicians, who then act as intermediaries between the manufacturer and patient.", "category": "Legal Theory", "url": "https://drugsmonitor.com/glossary/learned-intermediary", "markdownUrl": "https://drugsmonitor.com/data/glossary/learned-intermediary.md" }, { "slug": "preemption", "term": "Federal Preemption", "definition": "A legal doctrine that can bar state law claims when federal law occupies the field, as in certain claims against generic drug manufacturers.", "category": "Legal Theory", "url": "https://drugsmonitor.com/glossary/preemption", "markdownUrl": "https://drugsmonitor.com/data/glossary/preemption.md" }, { "slug": "class-action", "term": "Class Action", "definition": "A lawsuit where one or more plaintiffs represent a larger group (class) of people with similar claims against the same defendant.", "category": "Legal Procedure", "url": "https://drugsmonitor.com/glossary/class-action", "markdownUrl": "https://drugsmonitor.com/data/glossary/class-action.md" }, { "slug": "bellwether", "term": "Bellwether", "definition": "A representative trial case selected from a larger group of mass tort cases to guide settlement negotiations.", "category": "Legal Procedure", "url": "https://drugsmonitor.com/glossary/bellwether", "markdownUrl": "https://drugsmonitor.com/data/glossary/bellwether.md" }, { "slug": "discovery", "term": "Discovery", "definition": "The pretrial phase in which each party can obtain evidence from the opposing party through depositions, document requests, and interrogatories.", "category": "Legal Procedure", "url": "https://drugsmonitor.com/glossary/discovery", "markdownUrl": "https://drugsmonitor.com/data/glossary/discovery.md" }, { "slug": "summary-judgment", "term": "Summary Judgment", "definition": "A court ruling that there are no genuine factual disputes requiring a trial, allowing the court to decide the case based on the law alone.", "category": "Legal Procedure", "url": "https://drugsmonitor.com/glossary/summary-judgment", "markdownUrl": "https://drugsmonitor.com/data/glossary/summary-judgment.md" }, { "slug": "deposition", "term": "Deposition", "definition": "Sworn out-of-court testimony given by a witness or party under oath, used to gather evidence and establish trial testimony.", "category": "Legal Procedure", "url": "https://drugsmonitor.com/glossary/deposition", "markdownUrl": "https://drugsmonitor.com/data/glossary/deposition.md" }, { "slug": "causation-general-vs-specific", "term": "General vs. Specific Causation", "definition": "General causation asks whether a substance can cause a particular injury; specific causation asks whether it did cause that injury in a particular plaintiff.", "category": "Legal Theory", "url": "https://drugsmonitor.com/glossary/causation-general-vs-specific", "markdownUrl": "https://drugsmonitor.com/data/glossary/causation-general-vs-specific.md" }, { "slug": "daubert-standard", "term": "Daubert Standard", "definition": "A legal standard for determining whether expert testimony is admissible in federal court based on scientific reliability and relevance.", "category": "Legal Procedure", "url": "https://drugsmonitor.com/glossary/daubert-standard", "markdownUrl": "https://drugsmonitor.com/data/glossary/daubert-standard.md" }, { "slug": "global-settlement", "term": "Global Settlement", "definition": "A comprehensive settlement agreement that resolves a large group of cases against a defendant, often using a structured payment matrix.", "category": "Litigation Outcomes", "url": "https://drugsmonitor.com/glossary/global-settlement", "markdownUrl": "https://drugsmonitor.com/data/glossary/global-settlement.md" }, { "slug": "contingency-fee", "term": "Contingency Fee", "definition": "A fee arrangement where an attorney is paid a percentage of the client's recovery only if the case is successful.", "category": "Legal Fees", "url": "https://drugsmonitor.com/glossary/contingency-fee", "markdownUrl": "https://drugsmonitor.com/data/glossary/contingency-fee.md" }, { "slug": "mdl-consolidation", "term": "MDL Consolidation", "definition": "The process by which similar civil cases from multiple federal districts are transferred to a single court for coordinated pretrial proceedings.", "category": "Legal Procedure", "url": "https://drugsmonitor.com/glossary/mdl-consolidation", "markdownUrl": "https://drugsmonitor.com/data/glossary/mdl-consolidation.md" }, { "slug": "adverse-event-report", "term": "Adverse Event Report (AER)", "definition": "A report submitted to the FDA describing a negative medical occurrence associated with the use of a drug or medical device.", "category": "Regulatory", "url": "https://drugsmonitor.com/glossary/adverse-event-report", "markdownUrl": "https://drugsmonitor.com/data/glossary/adverse-event-report.md" }, { "slug": "off-label-use", "term": "Off-Label Use", "definition": "The use of an FDA-approved drug for a purpose, dosage, or patient population not included in the approved labeling.", "category": "Medical Practice", "url": "https://drugsmonitor.com/glossary/off-label-use", "markdownUrl": "https://drugsmonitor.com/data/glossary/off-label-use.md" }, { "slug": "medwatch", "term": "MedWatch", "definition": "The FDA's safety information and adverse event reporting program for healthcare professionals, patients, and consumers.", "category": "Regulatory", "url": "https://drugsmonitor.com/glossary/medwatch", "markdownUrl": "https://drugsmonitor.com/data/glossary/medwatch.md" }, { "slug": "faers", "term": "FDA Adverse Event Reporting System (FAERS)", "definition": "A computerized database designed to support the FDA's post-market safety surveillance program for approved drugs and therapeutic biologic products.", "category": "Regulatory", "url": "https://drugsmonitor.com/glossary/faers", "markdownUrl": "https://drugsmonitor.com/data/glossary/faers.md" }, { "slug": "boxed-warning", "term": "Boxed Warning (Black Box Warning)", "definition": "The strongest safety warning the FDA requires, appearing in a box at the top of a prescription drug's labeling to highlight serious or life-threatening risks.", "category": "Regulatory", "url": "https://drugsmonitor.com/glossary/boxed-warning", "markdownUrl": "https://drugsmonitor.com/data/glossary/boxed-warning.md" }, { "slug": "class-i-recall", "term": "Class I Recall", "definition": "The most serious FDA recall classification, indicating a reasonable probability that the product will cause serious adverse health consequences or death.", "category": "Regulatory", "url": "https://drugsmonitor.com/glossary/class-i-recall", "markdownUrl": "https://drugsmonitor.com/data/glossary/class-i-recall.md" }, { "slug": "compensatory-damages", "term": "Compensatory Damages", "definition": "Monetary compensation awarded to a plaintiff to cover actual losses caused by the defendant's conduct, including medical expenses, lost wages, and pain and suffering.", "category": "Damages", "url": "https://drugsmonitor.com/glossary/compensatory-damages", "markdownUrl": "https://drugsmonitor.com/data/glossary/compensatory-damages.md" }, { "slug": "punitive-damages", "term": "Punitive Damages", "definition": "Damages awarded to punish a defendant for egregious conduct and deter similar future behavior, beyond compensating the plaintiff for actual losses.", "category": "Damages", "url": "https://drugsmonitor.com/glossary/punitive-damages", "markdownUrl": "https://drugsmonitor.com/data/glossary/punitive-damages.md" }, { "slug": "joint-and-several-liability", "term": "Joint and Several Liability", "definition": "A legal rule allowing a plaintiff to recover the full amount of damages from any one defendant, regardless of that defendant's proportionate share of fault.", "category": "Legal Theory", "url": "https://drugsmonitor.com/glossary/joint-and-several-liability", "markdownUrl": "https://drugsmonitor.com/data/glossary/joint-and-several-liability.md" }, { "slug": "informed-consent", "term": "Informed Consent", "definition": "A process requiring healthcare providers to disclose the risks, benefits, and alternatives of a treatment so the patient can make a voluntary, knowledgeable decision.", "category": "Medical Practice", "url": "https://drugsmonitor.com/glossary/informed-consent", "markdownUrl": "https://drugsmonitor.com/data/glossary/informed-consent.md" }, { "slug": "discovery-rule", "term": "Discovery Rule", "definition": "A legal principle that delays the start of the statute of limitations until the plaintiff discovers or reasonably should have discovered the injury and its cause.", "category": "Legal Procedure", "url": "https://drugsmonitor.com/glossary/discovery-rule", "markdownUrl": "https://drugsmonitor.com/data/glossary/discovery-rule.md" }, { "slug": "medical-monitoring", "term": "Medical Monitoring", "definition": "A legal remedy allowing plaintiffs to recover the costs of ongoing medical testing to detect latent diseases from exposure to a harmful substance, even without current injury.", "category": "Damages", "url": "https://drugsmonitor.com/glossary/medical-monitoring", "markdownUrl": "https://drugsmonitor.com/data/glossary/medical-monitoring.md" }, { "slug": "bellwether-verdict-impact", "term": "Bellwether Verdict Impact on Settlement Value", "definition": "The influence that jury verdicts in test cases have on the overall settlement value of mass tort litigation.", "category": "Litigation Outcomes", "url": "https://drugsmonitor.com/glossary/bellwether-verdict-impact", "markdownUrl": "https://drugsmonitor.com/data/glossary/bellwether-verdict-impact.md" }, { "slug": "spoliation-of-evidence", "term": "Spoliation of Evidence", "definition": "The intentional or negligent destruction, alteration, or failure to preserve evidence that is relevant to pending or reasonably anticipated litigation.", "category": "Legal Procedure", "url": "https://drugsmonitor.com/glossary/spoliation-of-evidence", "markdownUrl": "https://drugsmonitor.com/data/glossary/spoliation-of-evidence.md" }, { "slug": "special-master", "term": "Special Master", "definition": "An attorney or retired judge appointed by the court to assist with case management, discovery disputes, or settlement negotiations in complex litigation like MDLs.", "category": "Legal Procedure", "url": "https://drugsmonitor.com/glossary/special-master", "markdownUrl": "https://drugsmonitor.com/data/glossary/special-master.md" }, { "slug": "leading-plaintiffs-counsel", "term": "Lead Plaintiffs' Counsel (LPC)", "definition": "Attorneys appointed by the court to lead the plaintiffs' side in consolidated litigation, coordinating strategy, discovery, and settlement negotiations.", "category": "Legal Procedure", "url": "https://drugsmonitor.com/glossary/leading-plaintiffs-counsel", "markdownUrl": "https://drugsmonitor.com/data/glossary/leading-plaintiffs-counsel.md" } ] }